IRIS
ORLANDI, ESTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.379
AS - Asia 2.025
EU - Europa 1.097
SA - Sud America 280
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 75
OC - Oceania 4
Totale 5.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.246
SG - Singapore 586
CN - Cina 484
HK - Hong Kong 355
RU - Federazione Russa 255
IT - Italia 234
VN - Vietnam 228
BR - Brasile 196
DE - Germania 150
BD - Bangladesh 147
FR - Francia 133
GB - Regno Unito 91
IE - Irlanda 65
IN - India 61
MX - Messico 57
CA - Canada 44
FI - Finlandia 40
ZA - Sudafrica 37
AR - Argentina 32
JP - Giappone 29
PL - Polonia 22
TR - Turchia 21
AT - Austria 17
IQ - Iraq 17
SE - Svezia 16
BE - Belgio 14
CO - Colombia 14
NL - Olanda 13
PK - Pakistan 12
VE - Venezuela 11
ID - Indonesia 10
MY - Malesia 10
EC - Ecuador 9
ES - Italia 9
JM - Giamaica 9
IL - Israele 8
SA - Arabia Saudita 8
TN - Tunisia 8
PT - Portogallo 7
CL - Cile 6
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
UA - Ucraina 6
UZ - Uzbekistan 6
LV - Lettonia 5
PH - Filippine 5
PY - Paraguay 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
ET - Etiopia 4
HN - Honduras 4
KE - Kenya 4
MA - Marocco 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
MD - Moldavia 1
MN - Mongolia 1
RS - Serbia 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 5.860
Salva come PNG Salva come JPEG
Città #
Dallas 506
San Jose 469
Hong Kong 344
Singapore 272
Ashburn 169
Beijing 135
Council Bluffs 115
Lauterbourg 93
Los Angeles 86
Ho Chi Minh City 74
Dublin 65
Redondo Beach 65
Santa Clara 62
Hanoi 61
New York 56
Munich 50
Boardman 44
Moscow 44
Mexico City 41
Falkenstein 40
Buffalo 38
Milan 37
Chandler 35
Johannesburg 30
Orem 25
Pavia 25
Shanghai 25
Tokyo 25
Montreal 24
Helsinki 21
São Paulo 21
Warsaw 20
Atlanta 17
London 17
Brooklyn 16
Turku 16
Changsha 15
Denver 15
Frankfurt am Main 15
Rome 15
Secaucus 15
Nuremberg 14
Brussels 13
Stockholm 13
Chennai 11
Da Nang 11
Haiphong 11
Boston 10
Chicago 10
Guangzhou 10
Seattle 10
Düsseldorf 9
Florence 9
Phoenix 9
Princeton 9
Turin 9
Belo Horizonte 8
Dhaka 8
Lawrence 8
Manchester 8
Medford 8
Wilmington 8
Ankara 7
Charlotte 7
Kingston 7
Kuala Lumpur 7
Amman 6
Ann Arbor 6
Baghdad 6
Brasília 6
Elk Grove Village 6
Figino 6
Hyderabad 6
Istanbul 6
Nanjing 6
Naples 6
Poplar 6
Rio de Janeiro 6
Tashkent 6
Toronto 6
Vienna 6
Buccinasco 5
Bến Tre 5
Guayaquil 5
Houston 5
Hải Dương 5
Jacksonville 5
Medellín 5
Mumbai 5
Paris 5
Pittsburgh 5
Porto Alegre 5
Riga 5
Riyadh 5
San Francisco 5
Addis Ababa 4
Amsterdam 4
Bari 4
Nanchang 4
New Delhi 4
Totale 3.672
Salva come PNG Salva come JPEG
Nome #
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 298
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 134
Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour 114
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 108
Intravoxel incoherent motion as a tool to detect early microstructural changes in meningiomas treated with proton therapy 104
Cancer Rehabilitation and Physical Activity: the "Oncology in Motion" Project 97
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 92
Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 92
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 89
Radiomics and dosiomics for predicting local control after carbon-ion radiotherapy in skull-base chordoma 86
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 85
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 81
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy 80
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 79
To a new normal in radiation oncology: looking back and planning forward 79
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 78
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia 77
Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy 76
Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? 76
A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients 75
NR4A3 fusion molecular profile change pathological diagnosis? A case report 72
Charged particle radiotherapy for thyroid cancer. A systematic review 68
Evaluation of endocrinological sequelae following particle therapy performed on anterior skull base lesions in the adult population 66
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 66
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 66
Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review 65
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation 64
Quality of life changes over time and predictors in a large head and neck patients’ cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study—a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 64
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 63
Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy 62
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 62
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 62
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? 61
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 60
The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment 60
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 59
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group 58
Baseline MRI-radiomics can predict overall survival in non endemic nasopharyngeal cancer patients 58
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 58
A Dosiomics Analysis Based on Linear Energy Transfer and Biological Dose Maps to Predict Local Recurrence in Sacral Chordomas after Carbon-Ion Radiotherapy 57
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936) 56
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC) 56
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 54
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 53
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 52
Are there any dosimetric predictors of acute toxicity during RT for NPC that can be modulated by genetic risk factors? 51
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 51
Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations 50
Neutron brachytherapy in the modern era: Indications and evidence 50
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 49
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 48
Current practice in proton therapy delivery in adult cancer patients across Europe 47
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 47
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 47
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer: Inter-fraction robustness in CIRT for pancreatic cancer 47
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 46
Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training 46
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 46
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 46
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 44
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 44
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy 43
Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma 43
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 43
How can we address the challenge of distant metastases in HNSCC prognosis? 42
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 42
Resection of the internal carotid artery in selected patients affected by cancer of the skull base 42
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group 41
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 41
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 39
Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature 38
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 38
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision 38
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity 38
Synthetic CT in Carbon Ion Radiotherapy of the Abdominal Site 37
Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy 37
Towards a European prospective data registry for particle therapy 36
How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy: RBE and LET in carbon ion therapy for sacral chordoma 36
Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review 36
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy 36
Radiotherapy and Medical Treatment 36
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 36
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 35
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 35
Current management and future challenges in salivary glands cancer 34
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 34
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 33
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 33
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 33
Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma 33
Repeatability and reproducibility of MRI-radiomic features: A phantom experiment on a 1.5 T scanner 32
Repeatability and reproducibility of MRI‐radiomic features: A phantom experiment on a 1.5 T scanner 32
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 31
The MUSES∗: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment 31
In Silico Feasibility Study of Carbon Ion Radiotherapy With Simultaneous Integrated Boost for Head and Neck Adenoid Cystic Carcinoma 31
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation 31
Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe? 31
Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO 31
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 31
Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma 30
Totale 5.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202243 0 1 0 3 0 2 1 3 4 3 4 22
2022/2023153 16 9 4 5 4 13 15 4 67 1 9 6
2023/2024107 8 9 3 8 7 14 6 16 3 2 19 12
2024/20251.345 11 25 10 10 10 103 211 116 318 56 107 368
2025/20264.101 265 555 287 409 387 130 587 174 368 376 362 201
2026/2027207 155 52 0 0 0 0 0 0 0 0 0 0
Totale 5.985